Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study

The optimal first‐line palliative systemic treatment strategy for metastatic esophagogastric cancer is not well defined. The aim of our study was to explore real‐world use of first‐line systemic treatment in esophagogastric cancer and assess the effect of treatment strategy on overall survival (OS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijksterhuis, Willemieke P.M., Verhoeven, Rob H.A., Slingerland, Marije, Haj Mohammad, Nadia, de Vos‐Geelen, Judith, Beerepoot, Laurens V., van Voorthuizen, Theo, Creemers, Geert‐Jan, van Oijen, Martijn G.H., van Laarhoven, Hanneke W.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027521/
https://www.ncbi.nlm.nih.gov/pubmed/31340065
http://dx.doi.org/10.1002/ijc.32580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027521/
https://www.ncbi.nlm.nih.gov/pubmed/31340065
http://dx.doi.org/10.1002/ijc.32580

Ejemplares similares